Etiology, Presentation, and Risk Factors for Diarrheal Syndromes in 3 Sub-Saharan African Countries After the Introduction of Rotavirus Vaccines From the Vaccine Impact on Diarrhea in Africa (VIDA) Study
Clinical Infectious Diseases · 19.04.2023 · 76 (Supplement_1) · S12-S22
DOI: 10.1093/cid/ciad022 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 19.04.2023. Verfasst von Andrea G Buchwald und 19 weiteren Autor:innen. Beteiligte Einrichtung: Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Rotavirus Vaccines, Cryptosporidiosis, Cryptosporidium, Dysentery. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bill & Melinda Gates Foundation.
Abstract (Originalsprache)
Background
Diarrheal disease is heterogeneous, including watery diarrhea (WD) and dysentery, some cases of which become persistent diarrhea (PD). Changes in risk over time necessitate updated knowledge of these syndromes in sub-Saharan Africa.
Methods
The Vaccine Impact on Diarrhea in Africa (VIDA) study was an age-stratified, case-control study of moderate-to-severe diarrhea among children <5 years old in The Gambia, Mali, and Kenya (2015–2018). We analyzed cases with follow-up of about 60 days after enrollment to detect PD (lasting ≥14 days), examined the features of WD and dysentery, and examined determinants for progression to and sequelae from PD. Data were compared with those from the Global Enteric Multicenter Study (GEMS) to detect temporal changes. Etiology was assessed from stool samples using pathogen attributable fractions (AFs), and predictors were assessed using χ2 tests or multivariate regression, where appropriate.
Results
Among 4606 children with moderate-to-severe diarrhea, 3895 (84.6%) had WD and 711 (15.4%) had dysentery. PD was more frequent among infants (11.3%) than in children 12–23 months (9.9%) or 24–59 months (7.3%), P = .001 and higher in Kenya (15.5%) than in The Gambia (9.3%) or Mali (4.3%), P < .001; the frequencies were similar among children with WD (9.7%) and those with dysentery (9.4%). Compared to children not treated with antibiotics, those who received antibiotics had a lower frequency of PD overall (7.4% vs 10.1%, P = .01), and particularly among those with WD (6.3% vs 10.0%; P = .01) but not among children with dysentery (8.5% vs 11.0%; P = .27). For those with watery PD, Cryptosporidium and norovirus had the highest AFs among infants (0.16 and 0.12, respectively), while Shigella had the highest AF (0.25) in older children. The odds of PD decreased significantly over time in Mali and Kenya while increasing significantly in The Gambia.
Conclusions
The burden of PD endures in sub-Saharan Africa, with nearly 10% of episodes of WD and dysentery becoming persistent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
- Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, USA.
- Division of Global Health Protection, Centers for Disease Control and Prevention, Nairobi, Kenya.
- Centre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.
- Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Banjul, The Gambia.
- Kenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.
Förderung
- Bill & Melinda Gates Foundation
Zitieren
APA
Buchwald, A. G., Verani, J. R., Keita, A. M., Jahangir Hossain, M., Roose, A., Sow, S. O., Omore, R., Doh, S., Jones, J. C. M., Nasrin, D., Zaman, S. M. A., Okoi, C., Antonio, M., Ochieng, J. B., Juma, J., Onwuchekwa, U., Powell, H., Platts-Mills, J. A., Tennant, S. M., & Kotloff, K. L. (2023). Etiology, Presentation, and Risk Factors for Diarrheal Syndromes in 3 Sub-Saharan African Countries After the Introduction of Rotavirus Vaccines From the Vaccine Impact on Diarrhea in Africa (VIDA) Study. Clinical Infectious Diseases, 76(Supplement_1), S12-S22. https://doi.org/10.1093/cid/ciad022
Vancouver
Buchwald AG, Verani JR, Keita AM, Jahangir Hossain M, Roose A, Sow SO, et al. Etiology, Presentation, and Risk Factors for Diarrheal Syndromes in 3 Sub-Saharan African Countries After the Introduction of Rotavirus Vaccines From the Vaccine Impact on Diarrhea in Africa (VIDA) Study. Clinical Infectious Diseases. 2023;76(Supplement_1):S12-S22. doi:10.1093/cid/ciad022
BibTeX
@article{Buchwald2023,
author = {Buchwald, Andrea G and Verani, Jennifer R and Keita, Adama Mamby and Jahangir Hossain, M and Roose, Anna and Sow, Samba O and Omore, Richard and Doh, Sanogo and Jones, Joquina Chiquita M and Nasrin, Dilruba and Zaman, Syed M A and Okoi, Catherine and Antonio, Martin and Ochieng, John B and Juma, Jane and Onwuchekwa, Uma and Powell, Helen and Platts-Mills, James A and Tennant, Sharon M and Kotloff, Karen L},
title = {Etiology, Presentation, and Risk Factors for Diarrheal Syndromes in 3 Sub-Saharan African Countries After the Introduction of Rotavirus Vaccines From the Vaccine Impact on Diarrhea in Africa (VIDA) Study},
journal = {Clinical Infectious Diseases},
year = {2023},
volume = {76},
number = {Supplement_1},
pages = {S12--S22},
doi = {10.1093/cid/ciad022}
}
EUVIMED